The association between AKT3 (AKT Serine/Threonine Kinase 3) and Bardet-Biedl Syndrome 16 is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants49
Symptoms35
Compounds0
Trials0
Publications3
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.